NCT05548296: An ongoing trial by Acrivon Therapeutics
This trial is ongoing. It must report results 2 years from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05548296 |
|---|---|
| Title | A Phase 2 Study of ACR-368 Therapy in Subjects With Endometrial Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 29, 2022 |
| Completion date | May 30, 2027 |
| Required reporting date | May 29, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 26, 2026 |
| Days late | None |